Label: SENOKOT-S- docuset sodium pill

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated May 25, 2014

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active Ingredients (in each tablet)

    Docusate sodium 50 mg

    Sennosides 8.6 mg

  • PURPOSE

    Purpose

    Stool Softner

    Laxative

  • KEEP OUT OF REACH OF CHILDREN

    Keep Out of Reach of Children

    In case of overdose, get medical help or contact

    a Poison Control Center right away.

  • INDICATIONS & USAGE

    Uses

    Relieves occasional constipation (irregularity)

    Generally causes a bowel movement in 6-12 hours

  • WARNINGS

    Warnings

    Do Not Use

    If you are now taking mineral oil,

    unless directed by a doctor

    Laxative products for longer than 1 week,

    unless directed by a doctor

  • DOSAGE & ADMINISTRATION

    Directions - take preferably at bedtime or as directed by a doctor

    Age                                                                     Starting dose                                    Maximum Dose

    Adults and children 12 years of age or older     2 tablets once a day -                               4 tablets twice a day

    children 6 to 12 years of age -                         1 tablet once a day                                    2 tablets twice a day

    children 2 to 6 years of age                              1/2 tablet once a day                              1 tablet twice a day

    children under 2 years of age                           ask a doctor  

  • INACTIVE INGREDIENT

    Enter section

  • ASK DOCTOR

    Ask a doctor before use if your have rectal bleeding or fail to have

    a bowel movement after use of a laxative. These may be signs of   

    a serious condition

  • PREGNANCY

    If pregnant or breast-feeding ask a health professional before use

  • PRINCIPAL DISPLAY PANEL

    copy of label

  • INGREDIENTS AND APPEARANCE
    SENOKOT-S 
    docuset sodium pill
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42787-105
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg  in 340 mg
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg  in 340 mg
    Inactive Ingredients
    Ingredient NameStrength
    COLLOIDAL SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    TALC (UNII: 7SEV7J4R1U)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    Product Characteristics
    Colororange (orange color) Scoreno score
    ShapeROUND (Pill) Size10mm
    FlavorImprint Code C18
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:42787-105-121 in 1 BOX
    150000 mg in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart33409/01/2012
    Labeler - Ajes Pharmaceuticals,LLC (159945393)
    Establishment
    NameAddressID/FEIBusiness Operations
    Ajes Pharmaceuticals,LLC159945393manufacture(42787-105) , repack(42787-105) , relabel(42787-105)